David Main is the founder of Notch Therapeutics. Notch Therapeutics has raised $85M in total funding. Latest round: Series A. Based in Toronto, Canada.
David Main was appointed as President and Chief Executive Officer of Notch Therapeutics to advance the company's gene-edited iPSC-derived immune cell therapeutics. Notch Therapeutics was founded in 2018 by University of Toronto researchers and develops renewable stem-cell-derived immunotherapies for cancer.
Full founder directory · Investor directory · Company funding database · Fundraising library